ATYR
aTyr Pharma·NASDAQ
--
--(--)
--
--(--)
3.75 / 10
Netural
Analyst consensus is neutral (1 rating). Fund‑flow score is 7.5 (good) with overall inflow ratio 0.48 but negative trend; small, medium and large investors are net positive, extra‑large net negative.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-07
InstitutionRBC Capital
Times predicted2
Historical Win Rate0.0%
Is money flowing into or out of ATYR?
- ATYR holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.75/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
